OmniAb Investor Presentation Deck slide image

OmniAb Investor Presentation Deck

What is Biological Intelligence ™M? ● We believe that antibodies generated in vivo are superior to ones from other sources because they are naturally optimized through an iterative process that preferentially selects for antibodies with excellent specificity and developability profiles The ability of the immune system in our engineered transgenic animals to create optimized antibodies for human therapeutics is what we call Biological Intelligence ● • We believe this approach increases the efficiency and probability of success of therapeutic antibody discovery and may help limit the attrition of antibody product candidates in the clinic 13 OmniAb
View entire presentation